Colorectal cancer is the third most common cause of death fromcancer in the United States, after lung cancer and breast cancer.1A well-defined hereditary predisposition accounts for probably3 to 4 percent of cases of colorectal cancer. Conditions suchas familial adenomatous polyposis and the Lynch syndrome (alsoknown as hereditary nonpolyposis colorectal cancer) neverthelessrepresent important models, and their contribution to the understandingof mechanisms of carcinogenesis is out of proportion to theirfrequency. Within a family with the Lynch syndrome, opportunitiesfor genetic testing and enhanced surveillance exist. Becauseof the early age at the onset of . . . [Full Text of this Article]
Source Information
From the Creighton University School of Medicine, Omaha, Nebr. (H.T.L.); and the University of Texas M.D. Anderson Cancer Center, Houston (P.M.L.).
This article has been cited by other articles:
Barnetson, R. A., Tenesa, A., Farrington, S. M., Nicholl, I. D., Cetnarskyj, R., Porteous, M. E., Campbell, H., Dunlop, M. G.
(2006). Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.. NEJM
354: 2751-2763
[Abstract][Full Text]
Taylor, W. C.
(2006). A 71-Year-Old Woman Contemplating a Screening Colonoscopy. JAMA
295: 1161-1167
[Full Text]
Misak, A.
(2005). Is genetic screening for the Lynch syndrome effective?. CMAJ
172: 1557-1557
[Full Text]